Moderna, Inc.
Moderna
MRNA · NASDAQ
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2025
- Revenue
- $1.9B
- Assets
- $12.3B
- SEC filing
- DEF 14A
- Filed
- March 16, 2026
Executive Compensation
Compensation reported for Moderna’s named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Stéphane Bancel
Chief Executive Officer
$19.9M
Reported total
- Salary
- $1,677,739
- Stock awards
- $6,897,455
- Incentives
- $4,302,360
- Option awards
- $6,897,425
- Other
- $157,238
James Mock
Chief Financial Officer
$5.9M
Reported total
- Salary
- $852,192
- Stock awards
- $2,452,404
- Incentives
- $1,311,210
- Option awards
- $1,226,205
- Other
- $15,750
Shannon Thyme Klinger
Chief Legal Officer And Corporate Secretary
$5.4M
Reported total
- Salary
- $852,192
- Stock awards
- $2,145,838
- Incentives
- $1,311,210
- Option awards
- $1,072,924
- Other
- $15,750
Stéphane Bancel
Chief Executive Officer
$19.9M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed March 16, 2026.
- Salary
- $1.7M
- Stock Awards
- $6.9M
- Option Awards
- $6.9M
- Incentives
- $4.3M
- Other
- $157K
Historical Compensation
Stéphane Bancel total compensation, fiscal years 2023–2025.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,677,739 | $6,897,455 | $19,932,217 |
| 2024 | $1,625,885 | $7,654,730 | $19,876,180 |
| 2023 | $1,563,462 | $3,129,194 | $17,068,514 |
Named Executive Officers
Source information
- Company
- Moderna, Inc.
- Ticker
- MRNA · NASDAQ
- Filing type
- DEF 14A
- Fiscal year
- 2025
- Filing date
- March 16, 2026
- SEC accession number
- 0001308179-26-000081
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company